Trump said he wants to bring more drug manufacturing to the U.S. At a political fundraising dinner on Tuesday night, President Donald Trump said he plans to announce tariffs on pharmaceuticals soon.

Also Read: Lupin recalls over 16,000 bottles of generic tuberculosis drug in the US citing manufacturing issue Lupin isn’t the only one venturing into the digital therapeutics business.

The decades-long dream of creating a male equivalent of 'the pill' is moving closer to reality. Scientists in the US have begun testing a hormone-free contraceptive tablet in men called YCT-529.

Play the USA TODAY Daily Crossword Puzzle. The law also raised healthcare costs for seniors enrolled in the Medicare Part D drug benefit. In response to several changes to that program implemented ...

But how do they compare with traditional vitamin pills? Ali Rogin speaks with registered dietitian Shyla Davis-Cadogan to learn more. Making sure you get the right amount of daily vitamins can be ...

The Trump administration says it will not move forward with a Biden proposal that Medicare cover anti-obesity drugs such as Novo Nordisk’s Wegovy and Zepbound from Eli Lilly. The drugs have been ...

Knudsen stabilized the drug by adding fatty-acid chains, enabling it to bind to proteins in the blood, which prevents it from breaking down rapidly once injected. “It’s a tremendous honour to ...

If, in the future, tariffs on US pharma imports are levied, generics could get a lower tariff/exemption, and the financial impact on generics will be lower than innovators as generic drug prices are ...

Text “Alerts” to (201) 335-0739 or sign up here. How Much Would Drug Prices Increase Under Trump’s Tariffs? It’s unclear how pharmaceutical companies would respond to tariffs, including ...

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's ...

WASHINGTON, April 4 (Reuters) - The Trump administration's mass firings at the U.S. Food and Drug Administration have removed employees critical to reviewing new medicines, setting back years of ...

U.S.-listed shares of Novo fell 1.4% in aftermarket trading, while those of Eli Lilly (LLY.N), opens new tab, which makes obesity drug Zepbound, were down 3.1%. Sign up here. The proposal would ...